-
Mashup Score: 0Insights into the mechanism of action of fitusiran & the value of this agent in hemophilia treatment - 10 month(s) ago
Margaret Ragni, MD, MPH, University of Pittsburgh, Pittsburgh, PA, discusses the mechanism of action of fitusiran, and further discusses the…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Phase I study of ziftomenib with venetoclax or venetoclax/azacitidine or 7+3 in R/R AML - 10 month(s) ago
Amer Zeidan, MBBS, Yale University, New Haven, CT, comments on the efficacy of ziftomenib as a monotherapy in relapsed/refractory (R/R)…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RT @Dr_AmerZeidan: Very excited to open this study at @YaleCancer Published by @VJHemOnc https://t.co/kx4OMmwvm5
-
-
Mashup Score: 6Phase I study of ziftomenib with venetoclax or venetoclax/azacitidine or 7+3 in R/R AML - 10 month(s) ago
Amer Zeidan, MBBS, Yale University, New Haven, CT, comments on the efficacy of ziftomenib as a monotherapy in relapsed/refractory (R/R)…
Source: VJHemOncCategories: Hem/Oncs, Latest HeadlinesTweet-
Very excited to open this study at @YaleCancer Published by @VJHemOnc https://t.co/kx4OMmwvm5
-
-
Mashup Score: 5Exploring the safety & efficacy of magrolimab plus oral decitabine/cedazuridine in MDS - 10 month(s) ago
In this video, Amer Zeidan, MBBS, Yale University, New Haven, CT, shares some insights into a Phase II study which…
Source: VJHemOncCategories: Hem/Oncs, Latest HeadlinesTweet-
Another exciting study we just opened at @YaleCancer for higher risk #MDSsm Published by @VJHemOnc https://t.co/4IIjmNwPlH
-
-
Mashup Score: 9IMerge update: continuous transfusion independence & disease modification with imetelstat in LR-MDS - 10 month(s) ago
Amer Zeidan, MBBS, Yale University, New Haven, CT, shares the results of the Phase III IMerge study (NCT02598661) evaluating imetelstat…
Source: VJHemOncCategories: Hem/Oncs, Latest HeadlinesTweet-
It was a true pleasure to present these data in @ASCO #ASCO23 and can not wait to have the peer-reviewed publication out in near future. Would love to hear your thoughts on the data! Published by @VJHemOnc https://t.co/zroT5vmNFd
-
-
Mashup Score: 1Updates in the treatment and management of amyloidosis and the importance of the multidisciplinary team - 10 month(s) ago
Amyloidosis is a rare disease in which insoluble amyloid proteins are deposited in tissues or organs, resulting in organ damage….
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out this week's podcast, where leading experts share some insights into novel agents being explored in amyloidosis, and further highlight the importance of the MDT in this disease: 🎧 https://t.co/HIMDxV2Lq8 #Amyloidosis #HemOnc #RareDisease https://t.co/67Y1szduXM
-
-
Mashup Score: 0Advantages & uses of machine learning in the prognostication of AML - 10 month(s) ago
Shaun Fleming, MBBS, FRACP, FRCPA, Alfred Hospital, Melbourne, Australia, discusses the use of machine learning to prognosticate patients with acute…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At #EHA2023, we spoke to Shaun Fleming (@AlfredHealth) on the use of machine learning in the prognostication of AML. Check out the interview here: 🎥 https://t.co/MDJHUuk6co @EHA_Hematology #LeuSM #HemOnc #AMLsm
-
-
Mashup Score: 1Goals and work of the EAHAD gene therapy working group - 10 month(s) ago
Michiel Coppens, MD, PhD, Amsterdam UMC, Amsterdam, The Netherlands, talks about the European Association for Haemophilia and Allied Disorders (EAHAD)…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How can we make #GeneTherapy more accessible to patients? Michiel Coppens (@amsterdamumc) shares the work of the EAHAD gene therapy working group: 👉 https://t.co/BMFEGtsN7U 👈 #EHA2023 #Hemophilia
-
-
Mashup Score: 1Exploring the impact of magnesium levels on the outcomes of patients with LBCL receiving axi-cel - 10 month(s) ago
Patrizia Mondello, MD, PhD, Mayo Clinic, Rochester, MN, discusses a study in which single-cell analysis was used to investigate the…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our interview w/ @pattymondello of @MayoClinic, who shares some insights into a study investigating the impact of magnesium levels on the outcomes of patients with LBCL treated w/ axi-cel 👇: https://t.co/LpLavUru83 @icmlugano #17ICML #LymSM #DLBCL #CART #ImmunoOnc
-
-
Mashup Score: 0Updates in the treatment and management of amyloidosis and the importance of the multidisciplinary team - 10 month(s) ago
Amyloidosis is a rare disease in which insoluble amyloid proteins are deposited in tissues or organs, resulting in organ damage….
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Want to hear more about recent updates in the treatment and management of amyloidosis & the importance of the multidisciplinary team? Check out this week's podcast, featuring @mbeksac56, @myelomaMD & Efstathios Kastritis: 🎧 https://t.co/zmLsXDEBjq #Amyloidosis #HemOnc https://t.co/MhFqe9nbE9
-
Find out more about the mechanism of action of fitusiran & the value of this agent in hemophilia in our exclusive interview with Margaret Ragni (@PittTweet) 👇: https://t.co/iyWEyd2jbt @isth #ISTH2023 #Hemophilia